Takeda Cuts Jobs And Pushes Oncology After Patent Losses Nudge 2009 Sales Down 4.7%
This article was originally published in The Pink Sheet Daily
Executive Summary
Company announces three-year business plan to help spur growth through sales of new products, strengthening oncology and CNS portfolios, and acceleration of expansion in emerging markets.